N-cadherin antagonism is bronchoprotective in severe asthma models
Science Advances · 29.11.2024 · 10 (48)
DOI: 10.1126/sciadv.adp8872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 29.11.2024. Verfasst von Nicolas L Pereira und 16 weiteren Autor:innen. Beteiligte Einrichtung: Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes o…. Hauptthemen laut MEDLINE: Asthma, Cadherins, Disease Models, Animal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Severe asthma induces substantial mortality and chronic disability due to intractable airway obstruction, which may become resistant to currently available therapies including corticosteroids and β-adrenergic agonist bronchodilators. A key effector of these changes is exaggerated airway smooth muscle (ASM) cell contraction to spasmogens. No drugs in clinical use effectively prevent ASM hyperresponsiveness in asthma across all severities. We find that N-cadherin, a membrane cell-cell adhesion protein up-regulated in ASM from patients with severe asthma, is required for the development of airway obstruction induced by allergic airway inflammation in mice. Inhibition of N-cadherin by ADH-1 reduced airway hyperresponsiveness independent of allergic inflammation, prevented bronchoconstriction, and actively promoted bronchodilation of airways ex vivo. ADH-1 inhibited ASM contraction by disrupting N-cadherin–δ-catenin interactions, which decreased intracellular actin remodeling. These data provide evidence for an intercellular communication pathway mediating ASM contraction and identify N-cadherin as a potential therapeutic target for inhibiting bronchoconstriction in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Center for Vascular Biology Research, Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
- Division of Genetics and Genomics, Manton Center for Cell Discovery Research, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Rutgers Institute for Translational Medicine and Science, Child Health Institute of New Jersey, Rutgers, the State University of New Jersey, New Brunswick, NJ 08901, USA.
- Biological Imaging Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Nicolas L Pereira, Niccole Schaible, Ararat J Ablooglu, Erika Lin, Zheming An, Eric Gebski, William Jester, Nariman Balenga, Cynthia Koziol-White, Reynold A Panettieri, Sangita Choudhury, Ramaswamy Krishnan, Kirk M Druey
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
- Intramural NIH HHS
Zitieren
APA
Pereira, N. L., Schaible, N., Desai, A., Chan, E. C., Ablooglu, A. J., Capuano, J., Lin, E., An, Z., Gebski, E., Jester, W., Ganesan, S., Balenga, N., Koziol-White, C., Panettieri, R. A., Choudhury, S., Krishnan, R., & Druey, K. M. (2024). N-cadherin antagonism is bronchoprotective in severe asthma models. Science Advances, 10(48). https://doi.org/10.1126/sciadv.adp8872
Vancouver
Pereira NL, Schaible N, Desai A, Chan EC, Ablooglu AJ, Capuano J, et al. N-cadherin antagonism is bronchoprotective in severe asthma models. Science Advances. 2024;10(48). doi:10.1126/sciadv.adp8872
BibTeX
@article{Pereira2024,
author = {Pereira, Nicolas L and Schaible, Niccole and Desai, Abhishek and Chan, Eunice C and Ablooglu, Ararat J and Capuano, Jacqueline and Lin, Erika and An, Zheming and Gebski, Eric and Jester, William and Ganesan, Sundar and Balenga, Nariman and Koziol-White, Cynthia and Panettieri, Reynold A and Choudhury, Sangita and Krishnan, Ramaswamy and Druey, Kirk M},
title = {N-cadherin antagonism is bronchoprotective in severe asthma models},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {48},
doi = {10.1126/sciadv.adp8872}
}
EUVIMED